Key Highlights

  • USD 36.70 was the published market data price for Amrize (NYSE:AMRZ) on October 7, 2026, down 1.56%, next to a 52-week low of USD 36.55 and far below a high of USD 65.94.
  • USD 40 is BofA's new Amrize target, cut from USD 50 in an October 2, 2026 downgrade to Underperform that cited cement pricing, Canadian Demand and weak roofing volumes.
  • 8.6% was Amrize's second quarter Revenue growth to USD 3.494 billion, reported August 6, 2026, while adjusted EBITDA Margin fell 80 basis points to 28.2% on higher freight and fuel costs, the company said.
  • USD 35 is Truist's new target, cut from USD 48 on October 5, 2026 with a Hold rating, as published market data show analyst targets for Amrize (NYSE:AMRZ) fell across Wells Fargo, UBS and others.

Downgrades Pile Up

Amrize (NYSE:AMRZ) has slid about 30% this year and sat at USD 36.70 on October 7, 2026, according to published market data, within cents of its 52-week low. BofA downgraded the stock to Underperform on October 2, 2026 and cut its target to USD 40 from USD 50, one report dating the move to September 2. Truist followed on October 5 with a Hold rating and a USD 35 target, down from USD 48. Wells Fargo lowered its target to USD 40 and UBS to USD 42, while RBC and JPMorgan had turned more cautious in August and September. Simple arithmetic on two published numbers shows the price is about 44% below the 52-week high.

What the Analysts Are Reacting To

BofA projected only about 3% EBITDA and 6% Earnings Per Share annual growth over 2026 to 2028, and said U.S. cement prices and Canadian demand each account for roughly 30% of profits. It also pointed to a quiet hurricane season weakening roofing demand and to reporting issues since the spin-off. In the second quarter reported August 6, 2026, revenue rose 8.6% and organic growth was 6.7%, but Building Envelope adjusted EBITDA fell 5.2% on freight costs. Management cited oil-driven cost Inflation and guided 2026 revenue to USD 12.5 billion to USD 12.7 billion and adjusted EBITDA to USD 3.1 billion to USD 3.2 billion. Together these points shift the debate from Volume growth to profit conversion.

Risks, Peers and Dates

Cash flow is a concern: six-month free Cash Flow was negative USD 986 million, and Capital spending is about USD 900 million this year. Adjusted earnings per share of USD 0.88 reportedly missed a USD 0.92 consensus. Offsetting that, CEO Jan Jenisch bought 26,000 shares on September 2, 2026 at an average of USD 42.47, as reported, and published market data show a P/E near 16.5 and a Dividend Yield near 1.8%. Peers such as Vulcan Materials (NYSE:VMC) and Martin Marietta are the benchmark names for aggregates and cement valuation. Results are listed for October 26, 2026 in published market data, a date to verify. Any miss on cost pass-through could deepen the pressure.

Where Things Stand

Amrize (NYSE:AMRZ) is stuck near its 52-week low because a run of analyst downgrades and target cuts followed second quarter margin pressure, a cost-driven earnings outlook and worries about cement pricing, Canada and roofing. No new company announcement was found for October 7, 2026. The next test is the third quarter report, with cost inflation and cash flow the key items. Any recovery likely depends on pricing holding and fuel costs easing.